Treatment with rituximab in patients with polyneuropathy with anti-MAG antibodies

J Neurol. 2011 Sep;258(9):1717-9. doi: 10.1007/s00415-011-5994-0. Epub 2011 Mar 25.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal, Murine-Derived / administration & dosage*
  • Antirheumatic Agents / administration & dosage
  • Antirheumatic Agents / therapeutic use*
  • Autoantibodies / administration & dosage
  • Autoantibodies / therapeutic use*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myelin-Associated Glycoprotein / immunology*
  • Polyneuropathies / drug therapy*
  • Polyneuropathies / immunology*
  • Polyneuropathies / metabolism
  • Rituximab

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • Autoantibodies
  • Myelin-Associated Glycoprotein
  • Rituximab